A campaign warning tradespeople about the dangers of asbestos has won a prestigious international award. The Health and Safety Executive’s ‘hidden killer’ campaign came top in the health category of the European Excellence Awards, held in Vienna, whic…
The specter of a drug-resistant form of the deadly H5N1 avian influenza is a nightmare to keep public-health officials awake at night. Now, however, a study published this week (Dec…
Addex Pharmaceuticals (SWISS: ADXN) announced that based on preliminary review of the unblinded data from study 206, it has terminated development of ADX10059 for chronic indications, including long term treatment of gastroesophageal reflux disease and…
The specter of a drug-resistant form of the deadly H5N1 avian influenza is a nightmare to keep public health officials awake at night. Now, however, a study published this week (Dec…
Medicago Inc. (TSX-V: MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), reported positive interim results from a Phase I human cl…
Amneal Pharmaceuticals is pleased to announce that it has received U.S. FDA approval to manufacture Nizatidine Oral Solution in the 15 mg/mL strength effective November 18, 2009. It is an AA-rated, therapeutically equivalent alternative to Axid® Oral …
